Goldman Sachs Group »

Kalvista Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.1M 331k 12.25
2023-09-30 $2.0M 209k 9.63
2023-06-30 $2.6M 293k 9.00
2023-03-31 $2.2M 276k 7.86
2022-12-31 $2.3M 346k 6.76
2022-06-30 $3.0M 301k 9.85
2022-03-31 $2.5M 167k 14.74
2021-12-31 $1.3M 99k 13.23
2021-09-30 $1.2M 69k 17.46
2021-03-31 $1.4M 55k 25.69
2020-12-31 $201k 11k 19.02
2020-06-30 $445k 37k 12.10
2019-12-31 $360k 20k 17.81
2019-09-30 $546k 47k 11.59
2019-06-30 $463k 21k 22.14
2019-03-31 $1.1M 38k 28.63
2017-12-31 $151k 16k 9.72